Learn more

WUHAN YZY BIOPHARMA CO LTD

Overview
  • Total Patents
    51
  • GoodIP Patent Rank
    45,656
  • Filing trend
    ⇩ 100.0%
About

WUHAN YZY BIOPHARMA CO LTD has a total of 51 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in China, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are F-STAR BIOTECHNOLOGISCHE FORSCHUNGS- UND ENTW M B H, BAC IP B V and Numab Therapeutics AG.

Patent filings in countries

World map showing WUHAN YZY BIOPHARMA CO LTDs patent filings in countries
# Country Total Patents
#1 China 28
#2 United States 10
#3 WIPO (World Intellectual Property Organization) 9
#4 Taiwan 2
#5 Canada 1
#6 EPO (European Patent Office) 1

Patent filings per year

Chart showing WUHAN YZY BIOPHARMA CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zhou Pengfei 51
#2 Zhang Jing 31
#3 Fan Kesuo 14
#4 Yan Yongxiang 14
#5 Fang Lijuan 14
#6 Wang Tao 14
#7 Wang Rui 11
#8 Liu Yang 9
#9 Hu Lingli 8
#10 Zhou Xiang 8

Latest patents

Publication Filing date Title
WO2021047559A1 Split intein and recombinant polypeptide preparation method using same
WO2021003739A1 Tetravalent symmetric bispecific antibody
WO2020168554A1 Modified fc fragment, antibody comprising same, and application thereof
WO2020168555A1 Cd3 antigen binding fragment and application thereof
US2016090426A1 Construction and application of bispecific antibody EpCAM×CD3
US2016145339A1 Construction and application of bispecific antibody HER2xCD3
CN104833625A Early-stage evaluation method of stability of CHO cell line of expression recombinant antibody
CN104833797A ELISA method of detecting bispecific antibody MSBODY and application of the method
CN104818295A Method for preparing and screening cell line expressing bispecific antibody
CN104788567A A preparing method of bispecific antibodies targeting a mouse T lymphocyte CD3 and a human tumor antigen EpCAM, and applications of the bispecific antibodies
CN104830901A Construction method of murine tumor model and application thereof
CN104558191A Construction and application of bispecific antibody CD20*CD3
CN104592393A Construction method and application of bispecific antibody CD19*CD3
CN104829725A Construction and application of bispecific antibody CD133*CD3
CN104774268A Construction and application of bispecific antibody EGFR*CD3
CN104829726A Construction and application of bispecific antibody CD19*CD3
CN104558193A Preparation method and application of bispecific antibody targeting mouse T lymphocyte CD3 and human tumor antigen HER2
CN104829727A Construction and application of bispecific antibody CD19*CD3
CN104558192A Construction and application of bispecific antibody HER2*CD3
CN104592392A Construction method and application of bispecific antibody EpCAM*CD3